| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Cash (used in) provided by financing activities | -15,268 | -15,268 |
| Net (decrease) increase in cash and cash equivalents | -17,491,641 | -10,912,777 |
| Cash and cash equivalents at beginning of period | 94,429,824 | - |
| Cash and cash equivalents at end of period | 76,938,183 | - |
Context Therapeutics Inc. (CNTX)
Context Therapeutics Inc. (CNTX)